KRT18 and breast carcinoma: When stratified by specimen sources, the results (Figure 3B) indicated that reports which used serum to detect the expression of CK18 predicted a poor outcome of breast cancer (HR = 1.24, 95%CI: 1.11–1.38, P<0.0001) .